| Jamieson, S E; Peixoto-Rangel, A L; Hargrave, A C et al. (2010) Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun 11:374-83 |
| Arun, Veena; Noble, A Gwendolyn; Latkany, Paul et al. (2007) Cataracts in congenital toxoplasmosis. J AAPOS 11:551-4 |
| Johnson, Jennifer J; Roberts, Craig W; Pope, Constance et al. (2002) In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain. J Immunol 169:966-73 |
| Johnson, Jennifer; Suzuki, Yasuhiro; Mack, Douglas et al. (2002) Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol 32:179-85 |
| Roberts, F; Roberts, C W; Ferguson, D J et al. (2000) Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol 22:5-Jan |
| Roberts, F; McLeod, R (1999) Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today 15:51-7 |
| Mack, D G; Johnson, J J; Roberts, F et al. (1999) HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol 29:1351-8 |
| Zuther, E; Johnson, J J; Haselkorn, R et al. (1999) Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase. Proc Natl Acad Sci U S A 96:13387-92 |
| Estes, R; Vogel, N; Mack, D et al. (1998) Paclitaxel arrests growth of intracellular Toxoplasma gondii. Antimicrob Agents Chemother 42:2036-40 |
| Mets, M B; Holfels, E; Boyer, K M et al. (1997) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 123:1-16 |
Showing the most recent 10 out of 37 publications
